ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Susan G. Komen® Urges Swift Passage of Reintroduced SCREENS for Cancer Act

Legislation to Ensure Access to Life Saving Breast Cancer Care

Susan G. Komen®, the world’s leading breast cancer organization, today commended members of the U.S. House and Senate for reintroducing the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act. The legislation is led by Representatives Joe Morelle (D-NY-25) and Brian Fitzpatrick (R-PA-01).

The SCREENS for Cancer Act reauthorizes a critical program – the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) – that helps women across the country with low incomes who do not have adequate insurance gain access to timely breast and cervical cancer screening, diagnostic, and treatment services.

“Access to timely, high-quality screening and diagnostic services is critical for saving lives, yet far too many people—especially those without adequate insurance—face delays or are unable to access this essential care,” said Molly Guthrie, VP of Policy & Advocacy at Susan G. Komen. “The SCREENS for Cancer Act would help enable earlier detection of breast cancer when treatment options are more effective, and the prognosis is better. Komen is grateful for the leadership of Congressmen Morelle and Fitzpatrick on this legislation and urges Congress to pass it quickly.”

"Cancer has touched my family in the most personal way, and I know firsthand the fear and uncertainty that comes with a diagnosis,” said Rep. Morelle. “Far too many people—especially those in underserved communities—face barriers to lifesaving screenings that could catch cancer early and save lives. I’m proud to introduce the bipartisan SCREENS for Cancer Act with Rep. Fitzpatrick, which will expand access to breast and cervical cancer screenings, ensuring that more people get the care they need. Early detection saves lives, and no one should go without screenings because of their income or insurance status."

Since its founding in 1991, NBCCEDP-funded programs have served more than 6.4 million individuals across the country and provided more than 16.5 million breast and cervical cancer screening examinations, resulting in the diagnosis of nearly 80,000 invasive breast cancers. The program also provides public education, outreach, patient navigation and care coordination to increase breast and cervical cancer screening rates and reach underserved, vulnerable populations.

“Every year, too many lives are lost because cancer is detected too late. By modernizing and expanding the National Breast and Cervical Cancer Early Detection Program, we are taking a step forward in removing barriers that prevent too many women—especially those in underserved communities—from getting the screenings that could save their lives. As Co-Chair of the House Cancer Caucus, I remain committed to advancing bipartisan solutions that put prevention and access at the forefront, and I thank Rep. Morelle for his partnership in this critical initiative,” said Rep. Fitzpatrick.

This bill had widespread, bipartisan support in the 118th Congress and passed key committees in both the Senate and House of Representatives. Susan G. Komen urges the 119th Congress to pass the SCREENS for Cancer Act without delay. Immediate action is critical to make meaningful progress in the fight against breast cancer and to ensure that all Americans have access to the screenings they need for early, life-saving intervention.

Learn more about Susan G. Komen’s Center for Public Policy at: https://www.komen.org/how-to-help/advocacy/center-for-public-policy/

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

“The SCREENS for Cancer Act would help enable earlier detection of breast cancer when treatment options are more effective, and the prognosis is better."

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.